At Roivant Discovery we have assembled a diverse leadership team with extensive experience across disciplines ranging from physics and computer-aided drug design to chemistry and structural biology. This continuum of complementary experience is essential for driving our scientific vision and bringing innovative therapeutics to patients in need.
Leadership Team
-
Matt Maisak, Ph.D.
Chief Operating Officer, Roivant Platforms
-
Woody Sherman, Ph.D.
Chief Computational Scientist
-
Pamela Carroll, Ph.D.
Chief Business Officer
-
Iván Cornella-Taracido, Ph.D.
Vice-President of Translational Chemical Biology
-
Huafeng Xu, Ph.D.
Chief Technology Officer
-
Eric Valeur, Ph.D.
Vice President, Head of Drug Discovery
-
Christopher G. Winter, Ph.D.
Head of Portfolio Strategy
-
Jason Imbriglio, Ph.D.
Vice President, Head of Platform Technology
-
Anthony Partridge, Ph.D.
Vice President, Head of Biology and Pharmacology